ʻO ka SARS-CoV-2 Antigen Rapid Test (Colloidal Gold) i manaʻo ʻia no ka ʻike qualitative o ka SARS-CoV-2 Antigen (Nucleocapsid protein) i nā specimens swab nasal in vitro. Hōʻike nā hopena maikaʻi i ke ola ʻana o ka antigen SARS-CoV-2. Pono e ʻike hou ʻia ma ka hoʻohui ʻana i ka mōʻaukala o ka mea maʻi a me nā ʻike diagnostic ʻē aʻe [1]. ʻAʻole kāpae nā hopena maikaʻi i ka maʻi bacteria a i ʻole nā ​​maʻi viral ʻē aʻe. ʻAʻole pono nā pathogens i ʻike ʻia ke kumu nui o nā hōʻailona maʻi. ʻAʻole kāpae nā hopena maikaʻi ʻole i ka maʻi SARS-CoV-2, a ʻaʻole pono ke kumu wale nō no ka mālama ʻana a i ʻole nā ​​​​hoʻoholo hoʻokele maʻi (me nā hoʻoholo hoʻomalu maʻi). E hoʻolohe i ka mōʻaukala pili hou o ka mea maʻi, ka mōʻaukala lapaʻau a me nā hōʻailona like o COVID-19, inā pono, ua ʻōlelo ʻia e hōʻoia i kēia mau laʻana ma o ka hoʻāʻo PCR no ka hoʻokele maʻi. No nā limahana keʻena hoʻokolohua i loaʻa i ke alakaʻi ʻoihana a i ʻole ke aʻo ʻana a loaʻa ka ʻike ʻoihana o ka hōʻailona in vitro, no nā limahana pili i loaʻa i ka hoʻomalu maʻi a i ʻole ke aʻo kahu maʻi [2].